Pan-cancer integrative histology-genomic analysis via multimodal deep learning

被引:119
|
作者
Chen, Richard J. [1 ,2 ,3 ,4 ,5 ]
Lu, Ming Y. [1 ,2 ,4 ,5 ,6 ,8 ]
Williamson, Drew F. K. [1 ,2 ,4 ,5 ,8 ]
Chen, Tiffany Y. [1 ,4 ,5 ,8 ]
Lipkova, Jana [1 ,4 ,5 ]
Noor, Zahra [1 ]
Shaban, Muhammad [1 ,2 ,4 ,5 ]
Shady, Maha [1 ,3 ,4 ,5 ]
Williams, Mane [1 ,2 ,3 ,4 ,5 ]
Joo, Bumjin [1 ]
Mahmood, Faisal [1 ,2 ,4 ,5 ,7 ]
机构
[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA USA
[2] Harvard Med Sch, Mass Gen Hosp, Dept Pathol, Boston, MA USA
[3] Harvard Med Sch, Dept Biomed Informat, Boston, MA USA
[4] Broad Inst Harvard, Canc Program, Cambridge, MA USA
[5] MIT, Cambridge, MA USA
[6] Dana Farber Harvard Canc Inst, Canc Data Sci Program, Boston, MA USA
[7] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA USA
[8] Harvard Univ, Harvard Data Sci Initiat, Cambridge, MA USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
TARGETED THERAPY; LANDSCAPE; HETEROGENEITY; PROGNOSIS; CLASSIFICATION; ORGANIZATION; EFFICIENT; SYSTEM;
D O I
10.1016/j.ccell.2022.07.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The rapidly emerging field of computational pathology has demonstrated promise in developing objective prognostic models from histology images. However, most prognostic models are either based on histology or genomics alone and do not address how these data sources can be integrated to develop joint image-omic prognostic models. Additionally, identifying explainable morphological and molecular descriptors from these models that govern such prognosis is of interest. We use multimodal deep learning to jointly examine pathology whole-slide images and molecular profile data from 14 cancer types. Our weakly supervised, multimodal deep-learning algorithm is able to fuse these heterogeneous modalities to predict outcomes and discover prognostic features that correlate with poor and favorable outcomes. We present all analyses for morphological and molecular correlates of patient prognosis across the 14 cancer types at both a disease and a patient level in an interactive open-access database to allow for further exploration, biomarker discovery, and feature assessment.
引用
收藏
页码:865 / +
页数:20
相关论文
共 50 条
  • [41] Pan-cancer analysis of tumor metabolic landscape associated with genomic alterations
    Choi, Hongyoon
    Na, Kwon Joong
    [J]. MOLECULAR CANCER, 2018, 17
  • [42] Pan-Cancer Metastasis Prediction Based on Graph Deep Learning Method
    Xu, Yining
    Cui, Xinran
    Wang, Yadong
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [43] Pan-cancer analysis of tumor metabolic landscape associated with genomic alterations
    Hongyoon Choi
    Kwon Joong Na
    [J]. Molecular Cancer, 17
  • [44] An integrative pan-cancer analysis of WWC family genes and functional validation in lung cancer
    Huang, Hongmei
    Gu, Jiaji
    Kuang, Xinjie
    Yu, Yonghui
    Rao, Boqi
    Fang, Shenying
    Lu, Jiachun
    Qiu, Fuman
    [J]. CELLULAR SIGNALLING, 2024, 115
  • [45] Pan-cancer analysis of alternative splicing patterns and association to genomic aberrations
    Hayrynen, Sergei
    Nykter, Matti
    [J]. CANCER RESEARCH, 2016, 76
  • [46] An integrative pan-cancer analysis of the molecular characteristics of dietary restriction in tumour microenvironment
    Song, Xiaoyi
    Wei, Jiaxing
    Li, Yang
    Zhu, Wen
    Cai, Zhiyuan
    Li, Kunwei
    Wei, Jingyue
    Lu, Jieyu
    Pan, Wanping
    Li, Man
    [J]. EBIOMEDICINE, 2024, 102
  • [47] Integrative analysis of the role of BOLA2B in human pan-cancer
    Liang, Mingxing
    Fei, Yinjiao
    Wang, Yalin
    Chen, Wenquan
    Liu, Zhen
    Xu, Di
    Shen, Hongyu
    Zhou, Honglei
    Tang, Jinhai
    [J]. FRONTIERS IN GENETICS, 2023, 14
  • [48] An integrative pan-cancer analysis of COPB1 based on data mining
    Chen, Heyan
    Li, Kunlong
    Li, Yijun
    Xie, Peilin
    He, Jianjun
    Zhang, Huimin
    [J]. CANCER BIOMARKERS, 2021, 30 (01) : 13 - 27
  • [49] Pan-cancer analysis of neoepitopes
    Gabriel N. Teku
    Mauno Vihinen
    [J]. Scientific Reports, 8
  • [50] Pan-cancer identification of clinically relevant genomic subtypes using outcome-weighted integrative clustering
    Arora, Arshi
    Olshen, Adam B.
    Seshan, Venkatraman E.
    Shen, Ronglai
    [J]. GENOME MEDICINE, 2020, 12 (01)